XML 30 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring, Impairment and Costs of Terminated Program, and Impairment of Goodwill (Tables)
3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring, Impairment and Other Costs of Terminated Program

Restructuring, impairment and costs of terminated program includes the following (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

Clinical trial expense, other third-party and employee costs for the wind down of the bempegaldesleukin program

 

$

 

 

$

1,598

 

Severance and benefit expense

 

 

 

 

 

5,483

 

Impairment of right-of-use assets and property, plant and equipment

 

 

 

 

 

13,200

 

Contract termination and other restructuring costs

 

 

975

 

 

 

912

 

Restructuring, impairment and other costs of terminated program

 

$

975

 

 

$

21,193

 

The following table provides details regarding the severance and benefit expense for the three months ended March 31, 2024 pursuant to the 2023 Restructuring Plan and a reconciliation of the severance and benefits liability for the three months ended March 31, 2023 pursuant to the 2022 and 2023 Restructuring Plans, which we report within accrued expenses on our Condensed Consolidated Balance Sheet (in thousands):

 

 

 

Three Months Ended March 31, 2023

 

 

 

2023 Restructuring Plan

 

 

2022 Restructuring Plan

 

 

Total

 

Liability balance as of December 31, 2022

 

$

 

 

$

3,299

 

 

$

3,299

 

Expense recognized during the period

 

 

5,483

 

 

 

 

 

 

5,483

 

Payments during the period

 

 

 

 

 

(3,299

)

 

 

(3,299

)

Liability balance as of March 31, 2023

 

$

5,483

 

 

$

 

 

$

5,483

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2024

 

 

 

2023 Restructuring Plan

 

 

2022 Restructuring Plan

 

 

Total

 

Liability balance as of December 31, 2023

 

$

196

 

 

$

 

 

$

196

 

Expense recognized during the period

 

 

 

 

 

 

 

 

 

Payments during the period

 

 

(196

)

 

 

 

 

 

(196

)

Liability balance as of March 31, 2024

 

$

 

 

$

 

 

$

 

The following is a reconciliation of the impairment charges we recorded for the three months ended March 31, 2023, including the net book values of the sublease assets before the impairment and the fair values of the sublease assets (in thousands):

 

 

Three Months Ended March 31, 2023

 

 

 

Property, Plant and Equipment

 

 

Operating Lease Right-of-Use Assets

 

 

Total

 

Net book value of impaired facilities before write-off

 

$

5,114

 

 

$

28,434

 

 

$

33,548

 

Less: Fair value of impaired facilities — Level 3 of Fair Value Hierarchy

 

 

(3,314

)

 

 

(18,734

)

 

 

(22,048

)

Impairment expense for facilities

 

 

1,800

 

 

 

9,700

 

 

 

11,500

 

Impairment of other property, plant and equipment

 

 

1,700

 

 

 

 

 

 

1,700

 

Total impairment of right-of-use assets and property, plant and equipment

 

$

3,500

 

 

$

9,700

 

 

$

13,200

 

The following are reconciliations of the contract termination and other costs for the 2022 Restructuring Plan for the three months ended March 31, 2024 and 2023. We report $3.0 million within accrued expenses and the remaining within other long-term liabilities on our Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023.

 

 

For the Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

Liability balances as of December 31, 2023 and December 31, 2022, respectively

 

$

5,542

 

 

$

7,710

 

Expense recognized during the period

 

 

975

 

 

 

878

 

Payments during the period

 

 

(928

)

 

 

(1,095

)

Liability balances as of March 31, 2024 and March 31, 2023, respectively

 

$

5,589

 

 

$

7,493